Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Effects of p38 MAPK inhibition on early stages of diabetic retinopathy and sensory nerve function.

Du Y, Tang J, Li G, Berti-Mattera L, Lee CA, Bartkowski D, Gale D, Monahan J, Niesman MR, Alton G, Kern TS.

Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2158-64. doi: 10.1167/iovs.09-3674. Epub 2010 Jan 13. Erratum in: Invest Ophthalmol Vis Sci. 2011 Jul;52(8):6057. Li, Guanyuan [corrected to Li, Guangyuan].

2.

Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.

Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP.

Diabetes. 2007 Feb;56(2):373-9.

3.

Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia.

Li G, Tang J, Du Y, Lee CA, Kern TS.

Mol Vis. 2011;17:3156-65. Epub 2011 Dec 6.

5.

Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes.

Zheng L, Du Y, Miller C, Gubitosi-Klug RA, Ball S, Berkowitz BA, Kern TS.

Diabetologia. 2007 Sep;50(9):1987-96. Epub 2007 Jun 22. Erratum in: Diabetologia. 2007 Oct;50(10):2228.

PMID:
17583794
6.

Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.

Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrósio AF, Forrester JV.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5257-65.

PMID:
17962481
7.

Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.

Zhang JZ, Xi X, Gao L, Kern TS.

Curr Eye Res. 2007 Oct;32(10):883-9.

PMID:
17963108
8.

Deletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generation.

Tang J, Du Y, Petrash JM, Sheibani N, Kern TS.

PLoS One. 2013 Apr 16;8(4):e62081. doi: 10.1371/journal.pone.0062081. Print 2013.

9.

Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.

Kowluru RA, Odenbach S.

Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4161-6.

PMID:
15505070
10.

Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.

Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3972-8.

PMID:
11053301
11.

Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop.

Kern TS, Miller CM, Tang J, Du Y, Ball SL, Berti-Matera L.

Mol Vis. 2010 Aug 15;16:1629-39.

12.

Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro.

Tang J, Du Y, Lee CA, Talahalli R, Eells JT, Kern TS.

Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3681-90. doi: 10.1167/iovs.12-11018.

13.

Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.

Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S, Graves DT.

Am J Pathol. 2008 May;172(5):1411-8. doi: 10.2353/ajpath.2008.071070. Epub 2008 Apr 10.

14.

Curcumolide reduces diabetic retinal vascular leukostasis and leakage partly via inhibition of the p38MAPK/NF-κ B signaling.

Cai Y, Li W, Tu H, Chen N, Zhong Z, Yan P, Dong J.

Bioorg Med Chem Lett. 2017 Apr 15;27(8):1835-1839. doi: 10.1016/j.bmcl.2017.02.045. Epub 2017 Feb 22.

PMID:
28274631
16.

Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3.

Middlemas A, Delcroix JD, Sayers NM, Tomlinson DR, Fernyhough P.

Brain. 2003 Jul;126(Pt 7):1671-82. Epub 2003 Apr 22.

PMID:
12805110
17.

Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy.

Berkowitz BA, Roberts R, Luan H, Peysakhov J, Knoerzer DL, Connor JR, Hohman TC.

Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2954-60.

PMID:
16043871
18.

Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.

Campbell M, Collery R, McEvoy A, Gardiner TA, Stitt AW, Brankin B.

Curr Eye Res. 2006 Dec;31(12):1033-45.

PMID:
17169842
19.

Application of isoproterenol inhibits diabetic-like changes in the rat retina.

Jiang Y, Walker RJ, Kern TS, Steinle JJ.

Exp Eye Res. 2010 Aug;91(2):171-9. doi: 10.1016/j.exer.2010.04.014. Epub 2010 May 21.

20.

Supplemental Content

Support Center